Robert D. van Beek

A randomized trial investigating an exercise program to prevent reduction of bone mineral density and impairment of motor performance during treatment for childhood acute lymphoblastic leukemia

Annelies Hartman, M.L. te Winkel, Robert D. van Beek et al. · Pediatric Blood & Cancer · 2009 · 187 citations · Full text

Anti-Mullerian Hormone Is a Sensitive Serum Marker for Gonadal Function in Women Treated for Hodgkin’s Lymphoma during Childhood

Robert D. van Beek, Marry M. van den Heuvel‐Eibrink, Joop S.E. Laven et al. · The Journal of Clinical Endocrinology & Metabolism · 2007 · 185 citations · Full text

Inhibin B is superior to FSH as a serum marker for spermatogenesis in men treated for Hodgkin's lymphoma with chemotherapy during childhood

Robert D. van Beek, Martine J. Smit, Marry M. van den Heuvel‐Eibrink et al. · Human Reproduction · 2007 · 93 citations · Full text

No difference between prednisolone and dexamethasone treatment in bone mineral density and growth in long term survivors of childhood acute lymphoblastic leukemia

Robert D. van Beek, Sabine M.P.F. de Muinck Keizer‐Schrama, F.G.A.J. Hakvoort-Cammel et al. · Pediatric Blood & Cancer · 2005 · 49 citations

Pharmacogenetic risk factors for altered bone mineral density and body composition in pediatric acute lymphoblastic leukemia

M.L. te Winkel, Robert D. van Beek, Sabine M.P.F. de Muinck Keizer‐Schrama et al. · Haematologica · 2009 · 39 citations · Full text